coronavirus disease 2019 (COVID-19) and prevent disease progression. Despite global
usage, uncertainty remains regarding plasma efficacy, as randomized controlled trials
(RCTs) have provided divergent evidence regarding the survival benefit of convalescent
plasma. Here, we argue that during a global health emergency, the mosaic of evidence
originating from multiple levels of the epistemic hierarchy should inform contemporary policy …